2022
DOI: 10.1016/j.bpobgyn.2021.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Menopause hormone therapy, migraines, and thromboembolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 67 publications
0
2
0
Order By: Relevance
“…According to recent studies, it is estimated that approximately 1 in 10 individuals worldwide experience migraines ( Woldeamanuel and Cowan, 2017 ). Women are more commonly affected than men, with hormonal fluctuations playing a significant role in triggering migraine attacks ( Khandelwal et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to recent studies, it is estimated that approximately 1 in 10 individuals worldwide experience migraines ( Woldeamanuel and Cowan, 2017 ). Women are more commonly affected than men, with hormonal fluctuations playing a significant role in triggering migraine attacks ( Khandelwal et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%
“…Venous thromboembolism (VTE), primarily comprising deep vein thrombosis and its associated complication, pulmonary embolism, has the potential to cause severe and life-threatening consequences ( Lutsey and Zakai, 2023 ). Several observational studies have reported an increased risk of VTE among individuals with migraine ( Bushnell et al, 2009 ; Wabnitz and Bushnell, 2015 ; Khandelwal et al, 2022 ). A large population based cohort study conducted by Adelborg et al (2018) involving over 50,000 migraine participants found that migraine patients had a significantly higher risk of VTE compared to controls.…”
Section: Introductionmentioning
confidence: 99%